Organic Letters
Letter
(e) Krall, N.; da Cruz, F. P.; Boutureira, O.; Bernardes, G. J. L. Nat.
Chem. 2016, 8, 103−113.
AUTHOR INFORMATION
■
Corresponding Author
ORCID
(10) For examples of tryptophan modification, see: (a) Antos, J. M.;
Francis, M. B. J. Am. Chem. Soc. 2004, 126, 10256−10257.
(b) Foettinger, A.; Melmer, M.; Leitner, A.; Lindner, W. Bioconjugate
Chem. 2007, 18, 1678−1683. (c) Antos, J. M.; McFarland, J. M.;
Iavarone, A. T.; Francis, M. B. J. Am. Chem. Soc. 2009, 131, 6301−6308.
(d) Ruiz-Rodríguez, J.; Albericio, F.; Lavilla, R. Chem. - Eur. J. 2010, 16,
1124−1127. (e) Popp, B. V.; Ball, Z. T. J. Am. Chem. Soc. 2010, 132,
6660−6662. (f) Chen, Z.; Popp, B. V.; Bovet, C. L.; Ball, Z. T. ACS
Chem. Biol. 2011, 6, 920−925. (g) Williams, T. J.; Reay, A. J.; Whitwood,
A. C.; Fairlamb, I. J. S. Chem. Commun. 2014, 50, 3052−3054. (h) Zhu,
Y.; Bauer, M.; Ackermann, L. Chem. - Eur. J. 2015, 21, 9980−9983.
(i) Seki, Y.; Ishiyama, T.; Sasaki, D.; Abe, J.; Sohma, Y.; Oisaki, K.; Kanai,
M. J. Am. Chem. Soc. 2016, 138, 10798−10801.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was supported by the NSF under the CCI Center for
Selective C−H Functionalization (CHE-1205646). We thank
DAAD (postdoctoral fellowship to H.F.T.K.), NSERC (graduate
scholarship to A.F.G.G.), NSF (predoctoral research fellowship
to D.C.D., No. DGE-1144469), the Gordon and Betty Moore
Foundation, Amgen, Abbott, Boehringer Ingelheim, and Caltech
for financial support. Larry Henling (Caltech) is acknowledged
for X-ray analysis, and Dr. Robert Craig and Dr. Guillaume
Lapointe (both Caltech) are thanked for helpful discussions.
(11) (a) Ferreira, E. M.; Stoltz, B. M. J. Am. Chem. Soc. 2003, 125,
9578−9579. (b) Stoltz, B. M. Chem. Lett. 2004, 33, 362−367.
(c) Krishnan, S.; Stoltz, B. M. Tetrahedron Lett. 2007, 48, 7571−7573.
(d) Ma, S.; Han, X.; Krishnan, S.; Virgil, S. C.; Stoltz, B. M. Angew.
Chem., Int. Ed. 2009, 48, 8037−8041. (e) Lee, C. W.; Han, S.-J.; Virgil, S.
C.; Stoltz, B. M. Tetrahedron 2015, 71, 3666−3670.
(12) (a) May, J. A.; Zeidan, R. K.; Stoltz, B. M. Tetrahedron Lett. 2003,
44, 1203−1205. (b) Han, S.-J.; Vogt, F.; Krishnan, S.; May, J. A.; Gatti,
M.; Virgil, S. C.; Stoltz, B. M. Org. Lett. 2014, 16, 3316−3319. (c) Han,
S.-J.; Vogt, F.; May, J. A.; Krishnan, S.; Gatti, M.; Virgil, S. C.; Stoltz, B.
M. J. Org. Chem. 2015, 80, 528−547. (d) Li, Z.; Geng, Q.; Lv, Z.;
Pritchett, B. P.; Baba, K.; Numajiri, Y.; Stoltz, B. M.; Liang, G. Org. Chem.
Front. 2015, 2, 236−240.
(13) (a) Kharasch, M. S.; Sosnovsky, G. J. Am. Chem. Soc. 1958, 80,
756. (b) Kharasch, M. S.; Fono, A. J. Org. Chem. 1958, 23, 324−325.
(c) Kharasch, M. S.; Fono, A. J. Org. Chem. 1959, 24, 72−78.
(14) Wang and co-workers reported the direct chlorooxidation of
indoles using CuCl2 and t-BuOOH to yield 3,3-disubstituted 3-
chlorooxindoles. The formation of a 3-peroxyoxindole was observed
as a byproduct in this reaction: Wang, H.; Liu, D.; Chen, H.; Li, J.; Wang,
D. Z. Tetrahedron 2015, 71, 7073−7076.
REFERENCES
■
(1) (a) Sundberg, R. J. The Chemistry of Indoles; Academic Press:
London, 1970. (b) Sundberg, R. J. Indoles; Academic Press: London,
1996. (c) Heterocyclic Scaffolds II: Reactions and Applications of Indoles;
Gribble, G. W., Ed.; Springer: Berlin, 2010.
(2) For reviews of the kynurenine pathway, see: (a) Sono, M.; Roach,
M. P.; Coulter, E. D.; Dawson, J. H. Chem. Rev. 1996, 96, 2841−2887.
(b) Stone, T. W.; Darlington, L. G. Nat. Rev. Drug Discovery 2002, 1,
609−620. (c) Millett, E. S.; Efimov, I.; Basran, J.; Handa, S.; Mowat, C.
G.; Raven, E. L. Curr. Opin. Chem. Biol. 2012, 16, 60−66. (d) Naismith, J.
H. Biochem. Soc. Trans. 2012, 40, 509−514. (e) Davis, I.; Liu, A. Expert
Rev. Neurother. 2015, 15, 719−721.
(15) Kong, D.-L.; Cheng, L.; Yue, T.; Wu, H.-R.; Feng, W.-C.; Wang,
D.; Liu, L. J. Org. Chem. 2016, 81, 5337−5344.
(16) Krylov, I. B.; Vil’, V. A.; Terent’ev, A. Beilstein J. Org. Chem. 2015,
11, 92−146.
(3) O’Connor, S. E.; Maresh, J. J. Nat. Prod. Rep. 2006, 23, 532−547.
(4) (a) Witkop, B. Justus Liebigs Ann. Chem. 1944, 556, 103−114. For a
review, see: (b) Mentel, M.; Breinbauer, R. Curr. Org. Chem. 2007, 11,
159−176.
(17) (a) An, G.; Zhou, W.; Zhang, G.; Sun, H.; Han, J.; Pan, Y. Org.
Lett. 2010, 12, 4482−4485. (b) Yang, Y.; Moinodeen, F.; Chin, W.; Ma,
T.; Jiang, Z.; Tan, C.-H. Org. Lett. 2012, 14, 4762−4765. (c) Arai, A.;
Tsuchiya, K.; Matsumura, E. Org. Lett. 2015, 17, 2416−2419.
(d) Nakamura, S.; Takahashi, S. Org. Lett. 2015, 17, 2590−2593.
(e) Liu, J.; Zhu, F.-M.; Chu, Y.-B.; Huang, L.-H.; Zhou, Y.-F.
Tetrahedron: Asymmetry 2015, 26, 1130−1137. (f) Kischkewitz, M.;
Daniliuc, C.-G.; Studer, A. Org. Lett. 2016, 18, 1206−1209.
(18) For a sequential Michael addition/oxidation/ring-cleavage
process of oxindoles, see: Miao, C.-B.; Zeng, Y.-M.; Shi, T.; Liu, R.;
Wei, P.-F.; Sun, X.-Q.; Yang, H.-T. J. Org. Chem. 2016, 81, 43−50.
(19) (a) Grob, C. A.; Schiess, P. W. Angew. Chem., Int. Ed. Engl. 1967, 6,
1−15. (b) Grob, C. A. Angew. Chem., Int. Ed. Engl. 1969, 8, 535−546.
(c) Prantz, K.; Mulzer, J. Chem. Rev. 2010, 110, 3741−3766.
(20) Kornblum, N.; DeLaMare, H. E. J. Am. Chem. Soc. 1951, 73, 880−
881.
(5) For selected examples, see: (a) Warnell, J. L.; Berg, C. P. J. Am.
Chem. Soc. 1954, 76, 1708−1709. (b) Brown, R. R.; Price, J. M. J. Am.
Chem. Soc. 1955, 77, 4158−4159. (c) Nakagawa, M.; Kato, S.; Fukazawa,
H.; Hasegawa, Y.; Miyazawa, J.; Hino, T. Tetrahedron Lett. 1985, 26,
5871−5874. (d) Ross, F. C.; Botting, N. P. Bioorg. Med. Chem. Lett.
1996, 6, 875−878. (e) Hamdy, M. S.; Scott, E. L.; Carr, R. H.; Sanders, J.
P. M. Catal. Lett. 2012, 142, 338−344. (f) Maitrani, C.; Heyes, D. J.;
Hay, S.; Arumugam, S.; Popik, V. V.; Phillips, R. S. Bioorg. Med. Chem.
Lett. 2012, 22, 2734−2737. (g) Kleijn, L. H. J.; Muskens, F. M.;
̈
Oppedijk, S. F.; de Bruin, G.; Martin, N. I. Tetrahedron Lett. 2012, 53,
6430−6432.
(6) For other examples of indole fragmentation methods, see:
(a) Closs, G.; Schwartz, G. J. Org. Chem. 1961, 26, 2609. (b) Ihara,
M.; Noguchi, K.; Fukumoto, K. Tetrahedron 1985, 41, 2109−2114.
(c) Shi, Z.; Zhang, B.; Cui, Y.; Jiao, N. Angew. Chem., Int. Ed. 2010, 49,
4036−4041. (d) Liu, M.; Shu, M.; Yao, C.; Yin, G.; Wang, D.; Huang, J.
Org. Lett. 2016, 18, 824−827.
(21) (a) Todorovski, T.; Fedorova, M.; Hennig, L.; Hoffmann, R. J.
Pept. Sci. 2011, 17, 256−262. (b) Lam, H. Y.; Zhang, Y.; Liu, H.; Xu, J.;
Wong, C. T. T.; Xu, C.; Li, X. J. Am. Chem. Soc. 2013, 135, 6272−6279.
(c) Wong, C. T. T.; Lam, H. Y.; Li, X. Org. Biomol. Chem. 2013, 11,
7616−7620.
(7) (a) Humphrey, G. R.; Kuethe, J. T. Chem. Rev. 2006, 106, 2875−
2911. (b) Vicente, R. Org. Biomol. Chem. 2011, 9, 6469−6480.
(c) Taber, D. F.; Tirunahari, P. K. Tetrahedron 2011, 67, 7195−7210.
(8) (a) Bandini, M.; Eichholzer, A. Angew. Chem., Int. Ed. 2009, 48,
9608−9664. (b) Bartoli, G.; Bencivenni, G.; Dalpozzo, R. Chem. Soc.
Rev. 2010, 39, 4449−4465. (c) Shiri, M. Chem. Rev. 2012, 112, 3508−
3549.
(9) For reviews of bioconjugation, see: (a) Hackenberger, C. P. R.;
Schwarzer, D. Angew. Chem., Int. Ed. 2008, 47, 10030−10074.
(b) Sletten, E. M.; Bertozzi, C. R. Angew. Chem., Int. Ed. 2009, 48,
6974−6998. (c) Spicer, C. D.; Davis, B. G. Nat. Commun. 2014, 5, 4740.
(d) Koniev, O.; Wagner, A. Chem. Soc. Rev. 2015, 44, 5495−5551.
(22) (a) Savige, W. E.; Fontana, A. J. Chem. Soc., Chem. Commun. 1976,
599−600. (b) Savige, W. E.; Fontana, A. Methods Enzymol. 1977, 47,
́ ́
442−453. (c) Szabo-Pusztay, K.; Szabo, L. Synthesis 1979, 1979, 276−
277. (d) Savige, W. E.; Fontana, A. Int. J. Pept. Protein Res. 1980, 15,
285−297.
D
Org. Lett. XXXX, XXX, XXX−XXX